IOL

Latest News


CME Content


Researchers conducted a 6-month study of patients implanted with the AcrySof IQ PanOptix presbyopia-correcting IOL to determine the binocular defocus curve of the lens. They concluded that these early results show good visual performance across the whole range of defocus. No unexpected adverse events were reported

In the past year, Matossian Eye Associates added a new category of presbyopia-correcting IOLs to the practice: the extended depth of focus (EDOF) IOL. The first IOL in this category is the Tecnis Symfony (Johnson & Johnson Vision). EDOF lenses from other manufacturers are in clinical trials, so it behooves the cataract surgeon to better understand how these lenses work.

Implantation of a sulcus-supported, pseudophakic supplementary intraocular lens (IOL) can be a safe and effective method for improving vision in eyes with residual refractive error after cataract extraction, refractive lens exchange, or keratoplasty, said Thomas Kohnen, MD, PhD. It also can be used to provide reversible presbyopia correction.

There are a number of ways to improve near vision for presbyopes, including multifocal intraocular lenses (IOLs)–traditional or low add–and pseudoaccommodative IOLs. It has been well documented that a small pupil and higher order aberrations, such as spherical aberration (SA) or coma, can increase depth of focus.

Aphakic eyes that have no or inadequate capsular support can pose a significant challenge to cataract surgeons. Careful attention to the preoperative considerations, appropriate intraocular lens choices, surgical techniques, and postoperative management can ensure optimal results.

When it comes to their eyes, patients want the safest treatments, and they know the best technology available is a laser. The cataract patient demographic is changing, and patients today have active lifestyles that demand functional vision.

IOL implantation was associated with more inflammation and slightly more visual obscuration in 120 children age 2 or younger undergoing bilateral cataract surgery. However, the rate of glaucoma was similar compared with an aphakic group.

When the topic of IOL implantation is on the table, the age of the patient does make a difference, according to pediatric expert Courtney Kraus, MD, who spoke at the Wilmer Eye Institute’s 27th annual Current Concepts in Ophthalmology conference.